Transplantation Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 255-259

  Tracey, James ^a   Zhang, Mei Jie ^a   Thiel, Elizabeth ^a   Sobocinski, Kathleen A ^a   Eapen, Mary ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Leukemia recurrence; TBI dose

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; FEMALE; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROBABILITY; SCHOOL CHILD; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84872606979     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.09.019     Document Type: Article

References (20)

1. Chessells J.M. The management of high-risk lymphoblastic leukaemia in children. Br J Haematol 2000, 108:204-216.
2. Borgmann A., von Stackelberg A., Hartmann R., et al. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 2003, 101:3835-3839.
3. Eapen M., Raetz E., Zhang M.J., et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006, 107:4961-4967.
4. Bensinger W. Hi-dose preparative regimens. Hematopoietic Cell Transplantation 1999, 1316-1332. Wiley-Blackwell Science, Chichester, UK. F. Appelbaum, S.J. Forman, R.S. Negrin (Eds.).
5. Davies S.M., Ramsay N.K., Klein J.P., et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000, 18:340-347.
6. Woods W.G., Ramsay N.K., Weisdorf D.J., et al. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Bone Marrow Transplant 1990, 6:9-16.
7. Snyder D.S., Chao N.J., Amylon M.D., et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993, 82:2920-2928.
8. Gassas A., Sung L., Saunders E.F., et al. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Bone Marrow Transplant 2006, 38:739-743.
9. Pulsipher M.A., Boucher K.M., Wall D., et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009, 114:1429-1436.
10. Verneris M.R., Eapen M., Duerst R., et al. Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2010, 16:1237-1244.
11. Survival Analysis: Statistical Methods for Censored and Truncated Data 2003, Springer-Verlag, New York. J. Klein, M.L. Moeschberger (Eds.).
12. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
13. Cox D. Regression models and life tables. J R Stat Soc 1972, 34:1187-1202.
14. Duerst R.E., Horan J.T., Liesveld J.L., et al. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Bone Marrow Transplant 2000, 25:489-494.
15. Marks D.I., Forman S.J., Blume K.G., et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant 2006, 12:438-453.
16. Oliansky D.M., Camitta B., Gaynon P., et al. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. Biol Blood Marrow Transplant 2012, 18:505-522.
17. Shaw P.J., Kan F., Woo Ahn K., et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood 2010, 116:4007-4015.
18. Spellman S.R., Eapen M., Logan B.R., et al. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood 2012, 120:259-265.
19. Curtis R.E., Rowlings P.A., Deeg H.J., et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997, 336:897-904.
20. Rizzo J.D., Curtis R.E., Socie G., et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009, 113:1175-1183.